bg
M

Merrimack Pharma (MACK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Merrimack Pharma (MACK)

Merrimack Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in designing novel treatments for cancer by targeting biomarker-defined cancers. Its clinical programs include MM-121 (seribantumab), MM-141 (istira... Read more

  • USD15.00
  • USD15.03
  • USD14.96
  • USD15.89
  • 2.00%
  • --
  • 109.46k
  • 214M
  • 11.53
  • 17.50%

Stock News

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Get The App